Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
RESEARCH TOOLSreports
Relmada Therapeutics (RLMD) Ownership - Who Owns Relmada Therapeutics?
277 Followers
Relmada Therapeutics (RLMD) Ownership Overview
2.04% Insiders
9.26% Mutual Funds
26.90% Other Institutional Investors
61.80% Public Companies and
Individual Investors
The ownership structure of Relmada Therapeutics (RLMD) stock is a mix of institutional, retail and individual investors. Approximately 36.16% of the company’s stock is owned by Institutional Investors, 2.04% is owned by Insiders and 61.80% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 31, 2024 | Sergio Traversa Ceo,director | Bought | $386479 |
| Jan 31, 2024 | Bought | $125533 | |
| Jan 31, 2024 | Ence Chuck Ca And Co | Bought | $150754 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,205,541 | Institution | 4.00% | 3,604,568 | |
| 1,205,541 | Institution | 4.00% | 3,604,568 | |
| 275,700 | Institution | 0.91% | 824,343 | |
| 252,294 | Institution | 0.84% | 754,359 | |
| 248,325 | Institution | 0.82% | 742,492 | |
| 224,846 | Institution | 0.75% | 672,290 | |
| 187,477 | Institution | 0.62% | 560,556 | |
| 110,669 | Institution | 0.37% | 330,900 | |
| 96,010 | Institution | 0.32% | 287,070 | |
| 95,691 | Institution | 0.32% | 286,116 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,205,541 | Institution | 4.00% | 3,604,568 | |
| 275,700 | Institution | 0.91% | 824,343 | |
| 252,294 | Institution | 0.84% | 754,359 | |
| 248,325 | Institution | 0.82% | 742,492 | |
| 187,477 | Institution | 0.62% | 560,556 | |
| 110,669 | Institution | 0.37% | 330,900 | |
| 96,010 | Institution | 0.32% | 287,070 | |
| 95,691 | Institution | 0.32% | 286,116 | |
| 73,915 | Institution | 0.24% | 221,006 | |
| 58,873 | Institution | 0.20% | 176,030 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 851,916 | Institution | 2.82% | 2,555,748 | |
| 353,625 | Institution | 1.17% | 1,060,875 | |
| 224,846 | Institution | 0.75% | 643,345 | |
| 90,028 | Institution | 0.30% | 269,184 | |
| 58,393 | Institution | 0.19% | 179,267 | |
| 6,548 | Institution | 0.02% | 176,731 | |
| 52,704 | Institution | 0.17% | 157,585 | |
| 31,618 | Institution | 0.10% | 94,538 | |
| 14,428 | Institution | 0.05% | 44,294 |
FAQ
Who Owns Relmada Therapeutics (RLMD)?
According to the latest TipRanks data, approximately 26.90% of the company's stock is held by institutional investors, 2.04% is held by insiders, and 61.80% is held by retail investors.
What percentage of Relmada Therapeutics (RLMD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 26.90% of Relmada Therapeutics (RLMD) stock is held by institutional investors.
What percentage of Relmada Therapeutics (RLMD) stock is held by retail investors?
According to the latest TipRanks data, approximately 61.80% of Relmada Therapeutics (RLMD) stock is held by retail investors.
Who owns the most shares of Relmada Therapeutics (RLMD)?
Vanguard owns the most shares of Relmada Therapeutics (RLMD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.